Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Butterfly Network (NYSE: BFLY) AI ultrasound thesis meets the Home Care launch test Butterfly Network (NYSE: BFLY) beat Q1 with 25% growth, 69% margins and a Midjourney deal. The Home Care launch in Q3 is the next real test. bySrinathJune 22, 2026